Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for ImmunoGen, Inc. (IMGN)

« Back to company index

IMGN Chatter Timeline

Stock Ticker for IMGN

Most Active Tweeters for IMGN

UserTweets
@newsfilterio 6
@Tickeron 6
@Rodrigo91261106 3
@TradeWithAlerts 3
@VatqLu 3

Recent Tweets for IMGN

Rodrigo91261106 @Rodrigo91261106
$IMGN Waiting for Buy signal on IMGN with https://t.co/sxj8WuVZJB https://t.co/hTE6txNSJ5
August 4th 2021, 11:08pm
Tickeron @Tickeron
$IMGN enters a Downtrend because Momentum Indicator dropped below the 0 level on August 3, 2021. View odds for this… https://t.co/7Wbqp4gnjF
August 4th 2021, 10:08pm
TradeWithAlerts @TradeWithAlerts
Large Print $IMGN Size: 150048 Price: 5.52 Time: 1600 Amount: $828,264.96 - Delayed - For real time prints subscrib… https://t.co/SKUjdik1Xy
August 4th 2021, 8:08pm
OptionHunt @OptionHunt
Ticker $IMGN Unusual Volume Detected: 61.51% over average
August 4th 2021, 2:08pm
Rodrigo91261106 @Rodrigo91261106
$IMGN Waiting for Buy signal on IMGN with https://t.co/sxj8WuVZJB https://t.co/SeN7ZH5d54
August 3rd 2021, 9:08pm
Tickeron @Tickeron
$IMGN in -1.06% Downtrend, falling for three consecutive days on July 30, 2021. View odds for this and other indica… https://t.co/YKnWcnRaUk
August 3rd 2021, 11:08am
newsfilterio @newsfilterio
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635 $IMGN https://t.co/9YdpUYQbBG
August 3rd 2021, 12:08am
otcdynamics @otcdynamics
$IMGN ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/2mWK3l0MU7
August 2nd 2021, 9:08pm
FlashAlert_me @FlashAlert_me
$IMGN [15s. delayed]: Issued Press Release on August 02, 16:30:00: ImmunoGen Announces Inducement Grants Under Nasd… https://t.co/cAj0JrOO5T
August 2nd 2021, 8:08pm
StockNewsBot2 @StockNewsBot2
$IMGN ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/H44nxrziLY
August 2nd 2021, 8:08pm
quantisnow @quantisnow
$IMGN ? ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/FhKopAvSHR This a… https://t.co/OPSMLuuIgk
August 2nd 2021, 8:08pm
stock_titan @stock_titan
$IMGN ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/PjFsiPsBtr
August 2nd 2021, 8:08pm
TradeWithAlerts @TradeWithAlerts
Large Print $IMGN Size: 166927 Price: 5.72 Time: 1600 Amount: $954,822.44 - Delayed - For real time prints subscrib… https://t.co/4HSF1YXqsU
August 2nd 2021, 8:08pm
QuantchaIdeas @QuantchaIdeas
Covered Call Alert: IMMUNOGEN $IMGN returning up to 70.78% through 21-Jan-2022 https://t.co/tBC8JcNGg1
August 2nd 2021, 4:08pm
QuantchaIdeas @QuantchaIdeas
Big Gainer Alert: Trading today’s 7.3% move in IMMUNOGEN $IMGN https://t.co/KMwWEGbXuR
August 2nd 2021, 3:08pm
VatqLu @VatqLu
$IMGN Waiting for Short signal https://t.co/Yw8eUKCloi
August 2nd 2021, 10:08am
ChartMill @ChartMill
Looking at the last year, $IMGN shows a very strong growth in Revenue. The Revenue has grown by 54.89%.… https://t.co/QeD4hi8YMN
August 1st 2021, 10:08pm
Rodrigo91261106 @Rodrigo91261106
$IMGN Waiting for Short signal on IMGN with https://t.co/sxj8WuVZJB https://t.co/EmkhsG8PDA
July 31st 2021, 8:07pm
CSIMarket @CSIMarket
$IMGN #StockMarket #Immunogen published second quarter of 2021 Earnings on https://t.co/savSNTKlN1: IMGN announced… https://t.co/jl42oKJDoP
July 31st 2021, 7:07pm
newsfilterio @newsfilterio
Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC $IMGN https://t.co/JwvvFrMcTW
July 31st 2021, 4:07pm
newsfilterio @newsfilterio
ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results $IMGN https://t.co/cIDWPKN69Y
July 31st 2021, 5:07am
newsfilterio @newsfilterio
Recap: Immunogen Q2 Earnings $IMGN https://t.co/qpRhuTdyJ2
July 31st 2021, 4:07am
newsfilterio @newsfilterio
ImmunoGen posts wider Q2 net loss as R&D expenses ramp $IMGN https://t.co/BJTxKT4DMO
July 31st 2021, 2:07am
EdgarInsider @EdgarInsider
A Form 10-Q [Quarterly Report] filing has been made with the SEC: $IMGN #ImmunoGen, Inc https://t.co/d08x6xT1lX
July 30th 2021, 9:07pm
quantisnow @quantisnow
$IMGN ? SEC Form 10-Q filed by ImmunoGen, Inc. https://t.co/fh8lZpgCQn 30s delayed.
July 30th 2021, 9:07pm
investor_feed @investor_feed
$IMGN 10-Q Immunogen (30 Jul, 5:12pm) ? 2021 Q2 Earnings https://t.co/3fluV9nbzU #IMGN #10Q #Immunogen #Earnings
July 30th 2021, 9:07pm
SeekingAlpha @SeekingAlpha
$IMGN - ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q2 2021 Results - Earnings Call Transcript.… https://t.co/IzYC6HpUmX
July 30th 2021, 6:07pm
AlertTrade @AlertTrade
UP WITH EARNINGS: $IMGN ImmunoGen, Inc https://t.co/Lzuz4IjeWv ? TradeIdeas via ? https://t.co/VS8RO1bzXJ
July 30th 2021, 3:07pm
SmallCapsDaily @SmallCapsDaily
$IMGN ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results Business Wire… https://t.co/fkYNM5qbTt
July 30th 2021, 3:07pm
EarningsAlley @EarningsAlley
ImmunoGen, Inc. $IMGN held an earnings call on 7/30/2021. Here are the highlights:
July 30th 2021, 3:07pm
earningsinfo @earningsinfo
$IMGN Q2 2021 Earnings Call https://t.co/4Tsa83fGCW
July 30th 2021, 3:07pm
Briefingcom @Briefingcom
$IMGN: Immunogen beats by $0.03, misses on revs; guides FY21 revs in-line https://t.co/jyHQoUrCMz
July 30th 2021, 12:07pm
ethanFlare @ethanFlare
$IMGN - ImmunoGen posts wider Q2 net loss as R&D expenses ramp Cap size: small, Float 90.3%, Short Interest 11.2%,… https://t.co/ATSDOetmDP
July 30th 2021, 11:07am
MarketCurrents @MarketCurrents
$IMGN - ImmunoGen posts wider Q2 net loss as R&D expenses ramp https://t.co/gUY3H4odXC
July 30th 2021, 11:07am
earningsinfo @earningsinfo
$IMGN ImmunoGen, inc Q2 2021 Earnings Call https://t.co/rjAS5S3mCG
July 30th 2021, 11:07am
otcdynamics @otcdynamics
$IMGN ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results https://t.co/Vold46gp0i
July 30th 2021, 11:07am
BenzingaMedia @BenzingaMedia
$IMGN, $IMGN Recap: Immunogen Q2 Earnings - https://t.co/Ad2lYRWUSX
July 30th 2021, 11:07am
mediasentiment @mediasentiment
$IMGN new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 261
July 30th 2021, 10:07am
mediasentiment @mediasentiment
$IMGN new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 260
July 30th 2021, 10:07am
newsfilterio @newsfilterio
ImmunoGen EPS beats by $0.03, misses on revenue $IMGN https://t.co/N1XFb8vzQ5
July 30th 2021, 10:07am
StockPods @StockPods
$IMGN Earnings Call Today: 8:00 AM EST Webcast: https://t.co/7LlcdRl0D5 Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99
July 30th 2021, 10:07am
EdgarInsider @EdgarInsider
Filing Alert, FORM 8-K [Press/News Current Report] available. $IMGN #ImmunoGen, Inc https://t.co/VgtKw5EgTy
July 30th 2021, 10:07am
StckPro @StckPro
$IMGN NEW ARTICLE : ImmunoGen EPS beats by $0.03, misses on revenue https://t.co/oPqJEADB2Q Get all the latest… https://t.co/g1yZt17U8C
July 30th 2021, 10:07am
FlashAlert_me @FlashAlert_me
$IMGN [15s. delayed] filed form 8-K on July 30, 06:36:41 https://t.co/qpuE8l1CtV
July 30th 2021, 10:07am
investor_feed @investor_feed
$IMGN 8-K Immunogen (30 Jul, 6:36am) ? ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Res… https://t.co/7RgnCfRxww
July 30th 2021, 10:07am
Market_Newswire @Market_Newswire
$IMGN SEC Filing: 8-K Earnings - ImmunoGen, Inc. (0000855654) July 30 undefined
July 30th 2021, 10:07am
ethanFlare @ethanFlare
$IMGN - ImmunoGen EPS beats by $0.03, misses on revenue Cap size: small, Float 90.3%, Short Interest 11.2%, Institu… https://t.co/X8pMeDfijd
July 30th 2021, 10:07am
MarketCurrents @MarketCurrents
$IMGN - ImmunoGen EPS beats by $0.03, misses on revenue https://t.co/JXc4bfHzQf
July 30th 2021, 10:07am
ImmunoGenInc @ImmunoGenInc
$IMGN Today we reported Q221 financial results and shared recent progress with the business. Full release here: https://t.co/ihJeuAL4RN
July 30th 2021, 10:07am
FlashAlert_me @FlashAlert_me
$IMGN [15s. delayed]: Issued Press Release on July 30, 06:30:00: ImmunoGen Reports Recent Progress and Second Quart… https://t.co/WnceIGvVTZ
July 30th 2021, 10:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.